Oral question asked in the House of Lords, by Baroness Pidgeon (Liberal Democrat). It was answered on Wednesday, 3 June 2026.
Alzheimer’s Disease: Diagnosis and Access to Experimental Drugs
- Question
-
My Lords, new research shows that finger-prick blood tests, alongside online brain tests, could revolutionise dementia diagnosis and offer a low-cost, scalable way to identify people who may be at higher risk of Alzheimer’s disease. What are the Government doing to support research in this area to enable the rollout of this innovative test?
- Answer
-
The noble Baroness has touched on a really important issue. There is an enormous amount of research going into this area, for very obvious reasons. This is one area that would make so much sense, and I am sure it has been picked up. What is important about the modern service framework is that all these measures are picked up and looked at. The speed with which we can fast-track research now is a fundamental factor in supporting the outcomes we are looking for.
Secondary information
- Type
- Oral question
- Reference
- 856 c834
- Session
- 2026-27
- Oral question type
- Supplementary
- Chamber / Committee
- House of Lords chamber
- Subjects
- Access Diagnosis Alzheimer's disease Drugs
- Link
- View this Oral question on hansard.parliament.uk
Librarians' tools
- Timestamp
- 2026-06-04 12:17:37 +0100
- URI
- http://hansard.intranet.data.parliament.uk/Lords/2026-06-03/26060326000036
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2026-06-03/26060326000036
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2026-06-03/26060326000036